<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">26297914</PMID>
      <DateCompleted>
        <Year>2016</Year>
        <Month>05</Month>
        <Day>18</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2018</Year>
        <Month>11</Month>
        <Day>13</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2049-632X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>73</Volume>
            <Issue>8</Issue>
            <PubDate>
              <Year>2015</Year>
              <Month>Nov</Month>
            </PubDate>
          </JournalIssue>
          <Title>Pathogens and disease</Title>
          <ISOAbbreviation>Pathog Dis</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Bordetella pertussis evolution in the (functional) genomics era.</ArticleTitle>
        <Pagination>
          <StartPage>ftv064</StartPage>
          <MedlinePgn>ftv064</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">ftv064</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1093/femspd/ftv064</ELocationID>
        <Abstract>
          <AbstractText>The incidence of whooping cough caused by Bordetella pertussis in many developed countries has risen dramatically in recent years. This has been linked to the use of an acellular pertussis vaccine. In addition, it is thought that B. pertussis is adapting under acellular vaccine mediated immune selection pressure, towards vaccine escape. Genomics-based approaches have revolutionized the ability to resolve the fine structure of the global B. pertussis population and its evolution during the era of vaccination. Here, we discuss the current picture of B. pertussis evolution and diversity in the light of the current resurgence, highlight import questions raised by recent studies in this area and discuss the role that functional genomics can play in addressing current knowledge gaps.</AbstractText>
          <CopyrightInformation>© FEMS 2015. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Belcher</LastName>
            <ForeName>Thomas</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biology and Biochemistry, University of Bath, Bath BA2 7AY, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Preston</LastName>
            <ForeName>Andrew</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biology and Biochemistry, University of Bath, Bath BA2 7AY, UK a.preston@bath.ac.uk.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2015</Year>
          <Month>08</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Pathog Dis</MedlineTA>
        <NlmUniqueID>101595366</NlmUniqueID>
        <ISSNLinking>2049-632X</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D010567">Pertussis Vaccine</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D001886" MajorTopicYN="N">Bordetella pertussis</DescriptorName>
          <QualifierName UI="Q000145" MajorTopicYN="Y">classification</QualifierName>
          <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
          <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D019143" MajorTopicYN="Y">Evolution, Molecular</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014644" MajorTopicYN="Y">Genetic Variation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016680" MajorTopicYN="Y">Genome, Bacterial</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D023281" MajorTopicYN="N">Genomics</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014943" MajorTopicYN="N">Global Health</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010567" MajorTopicYN="N">Pertussis Vaccine</DescriptorName>
          <QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName>
          <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012641" MajorTopicYN="N">Selection, Genetic</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014917" MajorTopicYN="N">Whooping Cough</DescriptorName>
          <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
          <QualifierName UI="Q000382" MajorTopicYN="Y">microbiology</QualifierName>
          <QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Bordetella pertussis</Keyword>
        <Keyword MajorTopicYN="N">diversity</Keyword>
        <Keyword MajorTopicYN="N">evolution</Keyword>
        <Keyword MajorTopicYN="N">genomics</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="accepted">
          <Year>2015</Year>
          <Month>7</Month>
          <Day>20</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2015</Year>
          <Month>8</Month>
          <Day>23</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2015</Year>
          <Month>8</Month>
          <Day>25</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2016</Year>
          <Month>5</Month>
          <Day>19</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">26297914</ArticleId>
        <ArticleId IdType="pmc">PMC4626590</ArticleId>
        <ArticleId IdType="doi">10.1093/femspd/ftv064</ArticleId>
        <ArticleId IdType="pii">ftv064</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Barkoff AM, Mertsola J, Guillot S, et al.  Appearance of Bordetella pertussis strains not expressing the vaccine antigen pertactin in Finland. ClinVaccine Immunol. 2012;19:1703–4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3485885</ArticleId>
            <ArticleId IdType="pubmed">22914363</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bart M, Harris S, Advani A. Global population structure and evolution of Bordetella Pertussis and their relationship with vaccination. MBio. 2014a;5:e01074.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3994516</ArticleId>
            <ArticleId IdType="pubmed">24757216</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bart MJ, Zeddeman A, van der Heide HG, et al.  Complete genome sequences of Bordetella pertussis isolates B1917 and B1920, representing two predominant global lineages. Genome Announc. 2014;2:e01391-14.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4276820</ArticleId>
            <ArticleId IdType="pubmed">25540342</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bouchez V, Caro V, Levillain E, et al.  Genomic content of Bordetella pertussis clinical isolates circulating in areas of intensive children vaccination. PloS One. 2008;3:e2437.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2413009</ArticleId>
            <ArticleId IdType="pubmed">18560590</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Burns DL, Meade BD, Messionnier NE. Pertussis resurgence: perspectives from the Working Group Meeting on pertussis on the causes, possible paths forward, and gaps in our knowledge. J Infect Dis. 2014;209:S32–5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24626870</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cherry JD. Pertussis—the trials and tribulations of old and new pertussis vaccines. Vaccine. 1992;10:1033–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1471425</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cherry JD. Acellular pertussis vaccines-a solution to the pertussis problem. J Infect Dis. 1993;168:21–4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8515111</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cherry JD. Historical review of pertussis and the classical vaccine. J Infect Dis. 1996;174:S259–63.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8896526</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Couturier E, Rocha EP. Replication-associated gene dosage effects shape the genomes of fast-growing bacteria but only for transcription and translation genes. Mol Microbiol. 2006;59:1506–18.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16468991</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Darling AC, Mau B, Blattner FR, et al.  Mauve: multiple alignment of conserved genomic sequence with rearrangements. Genome Res. 2004;14:1394–403.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC442156</ArticleId>
            <ArticleId IdType="pubmed">15231754</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Diavatopoulos DA, Cummings CA, Schouls LM, et al.  Bordetella pertussis, the causative agent of whooping cough, evolved from a distinct, human-associated lineage of B. bronchiseptica. PLoS Pathog. 2005;1:e45.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1323478</ArticleId>
            <ArticleId IdType="pubmed">16389302</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Elowitz MB, Levine AJ, Siggia ED, et al.  Stochastic gene expression in a single cell. Science. 2002;297:1183–6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12183631</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Harvill ET, Goodfield LL, Ivanov Y, et al.  Genome sequences of nine Bordetella holmesii strains isolated in the United States. Genome Announc. 2014;2:e00438-14.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4064020</ArticleId>
            <ArticleId IdType="pubmed">24948754</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hegerle N, Dore G, Guiso N. Pertactin deficient Bordetella pertussis present a better fitness in mice immunized with an acellular pertussis vaccine. Vaccine. 2014;32:6597–600.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25312274</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huygen K, Rodeghiero C, Govaerts D, et al.  Bordetella pertussis seroprevalence in Belgian adults aged 20–39 years, 2012. Epidemiol Infect. 2014;142:724–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24073712</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kallonen T, Grondahl-Yli-Hannuksela K, Elomaa A, et al.  Differences in the genomic content of Bordetella pertussis isolates before and after introduction of pertussis vaccines in four European countries. Infect Genet Evol. 2011;11:2034–42.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21964035</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>King AJ, van der Lee S, Mohangoo A, et al.  Genome-wide gene expression analysis of Bordetella pertussis isolates associated with a resurgence in pertussis: elucidation of factors involved in the increased fitness of epidemic strains. PloS One. 2013;8:e66150.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3679012</ArticleId>
            <ArticleId IdType="pubmed">23776625</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>King AJ, van Gorkom T, van der Heide HG, et al.  Changes in the genomic content of circulating Bordetella pertussis strains isolated from the Netherlands, Sweden, Japan and Australia: adaptive evolution or drift? BMC Genomics. 2010;11:64.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2834637</ArticleId>
            <ArticleId IdType="pubmed">20102608</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kurniawan J, Maharjan RP, Chan WF, et al.  Bordetella pertussis clones identified by multilocus variable-number tandem-repeat analysis. Emerg Infect Dis. 2010;16:297–300.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2957989</ArticleId>
            <ArticleId IdType="pubmed">20113564</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lam C, Octavia S, Bahrame Z, et al.  Selection and emergence of pertussis toxin promoter ptxP3 allele in the evolution of Bordetella pertussis. Infect Genet Evol. 2012;12:492–5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22293463</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lam C, Octavia S, Ricafort L, et al.  Rapid increase in pertactin-deficient Bordetella pertussis isolates, Australia. Emerg Infect Dis. 2014;20:626–33.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3966384</ArticleId>
            <ArticleId IdType="pubmed">24655754</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lapin JH.  Whooping Cough. Springfield, Ill: Charles C. Thomas; 1943. </Citation>
        </Reference>
        <Reference>
          <Citation>Liao YC, Lin SH, Lin HH. Completing bacterial genome assemblies: strategy and performance comparisons. Sci Rep. 2015;5:8747.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4348652</ArticleId>
            <ArticleId IdType="pubmed">25735824</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Litt DJ, Neal SE, Fry NK. Changes in genetic diversity of the Bordetella pertussis population in the United Kingdom between 1920 and 2006 reflect vaccination coverage and emergence of a single dominant clonal type. J Clin Microbiol. 2009;47:680–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2650949</ArticleId>
            <ArticleId IdType="pubmed">19158267</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lugauer S, Heininger U, Cherry JD, et al.  Long-term clinical effectiveness of an acellular pertussis component vaccine and a whole cell pertussis component vaccine. Eur J Pediatr. 2002;161:142–6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11998910</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Martin SW, Pawloski L, Williams M, et al.  Pertactin-negative Bordetella pertussis strains: evidence for a possible selective advantage. Clin Infect Dis. 2015;60:223–7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25301209</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mira A, Pushker R, Rodriguez-Valera F. The Neolithic revolution of bacterial genomes. Trends Microbiol. 2006;14:200–6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16569502</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mooi FR. Bordetella pertussis and vaccination: the persistence of a genetically monomorphic pathogen. Infect Genet Evol. 2010;10:36–49.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19879977</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mooi FR, Van Der Maas NA, De Melker HE. Pertussis resurgence: waning immunity and pathogen adaptation—two sides of the same coin. Epidemiol Infect. 2014;142:685–94.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23406868</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mooi FR, van Loo IH, van Gent M, et al.  Bordetella pertussis strains with increased toxin production associated with pertussis resurgence. Emerg Infect Dis. 2009;15:1206–13.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2815961</ArticleId>
            <ArticleId IdType="pubmed">19751581</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Otsuka N, Han HJ, Toyoizumi-Ajisaka H, et al.  Prevalence and genetic characterization of pertactin-deficient Bordetella pertussis in Japan. PloS One. 2012;7:e31985.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3279416</ArticleId>
            <ArticleId IdType="pubmed">22348138</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Parkhill J, Sebaihia M, Preston A, et al.  Comparative analysis of the genome sequences of Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica. Nat Genet. 2003;35:32–40.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12910271</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pawloski LC, Queenan AM, Cassiday PK, et al.  Prevalence and molecular characterization of pertactin-deficient Bordetella pertussis in the United States. Clin Vaccine Immunol. 2014;21:119–25.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3910938</ArticleId>
            <ArticleId IdType="pubmed">24256623</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Poolman JT. Shortcomings of pertussis vaccines: why we need a third generation vaccine. Expert Rev Vaccines. 2014;13:1159–62.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25089373</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Preston A, Parkhill J, Maskell DJ. The Bordetellae: lessons from genomics. Nat Rev Microbiol. 2004;2:379–90.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15100691</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Raser JM, O'Shea EK. Noise in gene expression: origins, consequences, and control. Science. 2005;309:2010–3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1360161</ArticleId>
            <ArticleId IdType="pubmed">16179466</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rendi-Wagner P, Kundi M, Mikolasek A, et al.  Hospital-based active surveillance of childhood pertussis in Austria from 1996 to 2003: estimates of incidence and vaccine effectiveness of whole-cell and acellular vaccine. Vaccine. 2006;24:5960–5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16757063</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ronn PF, Dalby T, Simonsen J, et al.  Seroepidemiology of pertussis in a cross-sectional study of an adult general population in Denmark. Epidemiol Infect. 2014;142:729–37.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24103353</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ross PJ, Sutton CE, Higgins S, et al.  Relative contribution of Th1 and Th17 cells in adaptive immunity to Bordetella pertussis: towards the rational design of an improved acellular pertussis vaccine. PLoS Pathog. 2013;9:e1003264.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3617212</ArticleId>
            <ArticleId IdType="pubmed">23592988</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Scott S, van der Sande M, Faye-Joof T, et al.  Seroprevalence of pertussis in the Gambia: evidence for continued circulation of bordetella pertussis despite high vaccination rates. Pediatr Infect Dis J. 2015;34:333–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4418845</ArticleId>
            <ArticleId IdType="pubmed">25764094</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sealey KL, Harris SR, Fry NK, et al.  Genomic analysis of isolates from the United Kingdom 2012 pertussis outbreak reveals that vaccine antigen genes are unusually fast evolving. J Infect Dis. 2015;212:294–301.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25489002</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>van Gent M, Bart MJ, van der Heide HG, et al.  Small mutations in Bordetella pertussis are associated with selective sweeps. PloS One. 2012;7:e46407.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3460923</ArticleId>
            <ArticleId IdType="pubmed">23029513</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>van Gent M, Heuvelman CJ, van der Heide HG, et al.  Analysis of Bordetella pertussis clinical isolates circulating in European countries during the period 1998–2012. Eur J Clin Microbiol. 2015;34:821–30.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4365279</ArticleId>
            <ArticleId IdType="pubmed">25527446</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>van Gent M, van Loo IH, Heuvelman KJ, et al.  Studies on Prn variation in the mouse model and comparison with epidemiological data. PloS One. 2011;6:e18014.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3064647</ArticleId>
            <ArticleId IdType="pubmed">21464955</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Warfel JM, Beren J, Kelly VK, et al.  Nonhuman primate model of pertussis. Infect Immun. 2012;80:1530–6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3318410</ArticleId>
            <ArticleId IdType="pubmed">22252879</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Warfel JM, Edwards KM. Pertussis vaccines and the challenge of inducing durable immunity. Curr Opin Immunol. 2015;35:48–54.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26091979</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Warfel JM, Zimmerman LI, Merkel TJ. Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model. P Natl Acad Sci USA. 2014;111:787–92.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3896208</ArticleId>
            <ArticleId IdType="pubmed">24277828</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>WHO. Geneva: WHO; 2014. Global and regional immunization profile.  http://www.who.int/immunization/monitoring_surveillance/data/gs_gloprofile.pdf?ua=1 (10 July 2015, date last accessed)</Citation>
        </Reference>
        <Reference>
          <Citation>Witt MA, Katz PH, Witt DJ. Unexpectedly limited durability of immunity following acellular pertussis vaccination in preadolescents in a North American outbreak. Clin Infect Dis. 2012;54:1730–5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22423127</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
